V CompBrief BY VELARION

Independent Director · Revolution Medicines, Inc. (RVMD)

Chair, Commercialization Committee

Frank K. Clyburn, Jr director compensation at Revoluti (FY2025): $419K

Fiscal year 2025 director compensation for Frank K. Clyburn, Jr at Revolution Medicines, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 27, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Frank K. Clyburn, Jr’s full pay file as a PDF — free

More than this page: up to 10 years of Frank’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Frank K. Clyburn, Jr and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Revolution Medicines Director Compensation Table · all 2 fiscal years held
In US dollars, as Revolution Medicines reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$69,391$105,169$244,937$0$419,497
FY2024$24,518$294,471$705,504—$1,024,493

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Revolution Medicines, Inc. DEF 14A filed April 27, 2026, accession 0001193125-26-182453, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Revolution Medicines, Inc. filed document, accession 0001193125-26-182453. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

Get the Revolution Medicines Board Governance Report

$419,497 Frank K. Clyburn, Jr, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 27, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Revolution Medicines pays directors a $50,000 cash retainer and $417,000 in Options and RSUs.

Committees

FY2025 · as the proxy prints them

Compensation · Commercialization (Chair)

The rest of the Revolution Medicines board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alexis BorisyLead Independent Director$481,225
Elizabeth McKee AndersonIndependent Director$461,620
Flavia Borellini, Ph.DIndependent Director$461,225
Lorence Kim, M.DIndependent Director$468,329
Sandra J. Horning, M.DIndependent Director$445,829
Sushil Patel, Ph.DIndependent Director$455,829
Thilo Schroeder, Ph.DIndependent Director—

The full Revolution Medicines compensation record

free company brief
Revolution Medicines, Inc. (RVMD) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within Revolution Medicines's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Revolution Medicines proxy · each links to its own free brief

Order RVMD

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report